Lithium and suicidal risk

Bipolar Disorders

Volumn 10, Issue 1, 2008, Pages 114-115

  Baldessarini, Ross J ^a,b   Tondo, Leonardo ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anticonvulsants; Attempts; Lithium; Meta analysis; Suicide

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LITHIUM; VALPROATE SEMISODIUM;

DRUG EFFICACY; HUMAN; LETTER; LONG TERM CARE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; LITHIUM; RISK; SUICIDE, ATTEMPTED;

EID: 38049132241     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2008.00550.x     Document Type: Letter

References (6)

1. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: A meta-analytic review. Bipolar Disord 2006; 8: 625-639.
2. Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord 2007; Aug 17, [e-publication ahead of print].
3. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior: Lithium, divalproex, and carbamazepine. J Affect Disord 2007; 103: 5-11.
4. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders: Data from a randomized prospective trial. Pharmacopsychiatry 1996; 29: 103-107.
5. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290: 1467-1473.
6. Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicidal risk in recurrent major depressive disorder. J Clin Psychiatry 2007; 68: 380-383.